2020 | BioSenic

Bone Therapeutics announces half-year results for 2020

Read more about Bone Therapeutics announces half-year results for 2020

Bone Therapeutics Business Update for the First Quarter of 2020

Read more about Bone Therapeutics Business Update for the First Quarter of 2020

2020 Annual Report

Read more about 2020 Annual Report

Financial Report H1 2020

Read more about Financial Report H1 2020

Transparency notification received from CPH Banque

Read more about Transparency notification received from CPH Banque

Bone Therapeutics: Information on the total number of voting rights and shares (December 2020)

Read more about Bone Therapeutics: Information on the total number of voting rights and shares (December 2020)

Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

Read more about Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

Bone Therapeutics announces pricing of private placement

Read more about Bone Therapeutics announces pricing of private placement

Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent

Read more about Bone Therapeutics announces completion of the acquisition of its cell therapy manufacturing subsidiary SCTS by Catalent

Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants

Read more about Bone Therapeutics, Cerhum, 3D-Side, mSKIL and IREC awarded €3M in BioWin supported funding to develop personalized, tissue engineered bone implants

Subscribe to 2020